243 related articles for article (PubMed ID: 26778149)
1. Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
Sangshetti JN; Kalam Khan FA; Kulkarni AA; Patil RH; Pachpinde AM; Lohar KS; Shinde DB
Bioorg Med Chem Lett; 2016 Feb; 26(3):829-835. PubMed ID: 26778149
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies.
Patil SR; Asrondkar A; Patil V; Sangshetti JN; Kalam Khan FA; Damale MG; Patil RH; Bobade AS; Shinde DB
Bioorg Med Chem Lett; 2017 Aug; 27(16):3845-3850. PubMed ID: 28693910
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents.
Taha M; Ismail NH; Imran S; Anouar EH; Selvaraj M; Jamil W; Ali M; Kashif SM; Rahim F; Khan KM; Adenan MI
Eur J Med Chem; 2017 Jan; 126():1021-1033. PubMed ID: 28012342
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antileishmanial activity and docking study of N'-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides.
Sangshetti JN; Shaikh RI; Khan FA; Patil RH; Marathe SD; Gade WN; Shinde DB
Bioorg Med Chem Lett; 2014 Mar; 24(6):1605-10. PubMed ID: 24513045
[TBL] [Abstract][Full Text] [Related]
5. Microwave-assisted synthesis of novel 5-substituted benzylidene amino-2-butyl benzofuran-3-yl-4-methoxyphenyl methanones as antileishmanial and antioxidant agents.
Patil SR; Bollikonda S; Patil RH; Sangshetti JN; Bobade AS; Asrondkar A; Reddy PP; Shinde DB
Bioorg Med Chem Lett; 2018 Feb; 28(3):482-487. PubMed ID: 29258770
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents.
Bekhit AA; Saudi MN; Hassan AM; Fahmy SM; Ibrahim TM; Ghareeb D; El-Seidy AM; Al-Qallaf SM; Habib HJ; Bekhit AEA
Future Med Chem; 2018 Oct; 10(19):2325-2344. PubMed ID: 30215271
[TBL] [Abstract][Full Text] [Related]
7. Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.
Khan FA; Zaheer Z; Sangshetti JN; Patil RH; Farooqui M
Bioorg Med Chem Lett; 2017 Feb; 27(3):567-573. PubMed ID: 28003139
[TBL] [Abstract][Full Text] [Related]
8. Insights about resveratrol analogs against trypanothione reductase of
da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
[TBL] [Abstract][Full Text] [Related]
9. Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase.
da Silva ER; Brogi S; Grillo A; Campiani G; Gemma S; Vieira PC; Maquiaveli CDC
Chem Biol Drug Des; 2019 Feb; 93(2):139-146. PubMed ID: 30216691
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Pharmacophoric Approach in the Design and Synthesis of Coumarin Linked Pyrazolinyl as Urease Inhibitors, Kinetic Mechanism and Molecular Docking.
Saeed A; Mahesar PA; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
Chem Biodivers; 2017 Aug; 14(8):. PubMed ID: 28574649
[TBL] [Abstract][Full Text] [Related]
13. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
14. Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.
De Luca L; Ferro S; Buemi MR; Monforte AM; Gitto R; Schirmeister T; Maes L; Rescifina A; Micale N
Chem Biol Drug Des; 2018 Sep; 92(3):1585-1596. PubMed ID: 29729080
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease.
Alomari M; Taha M; Imran S; Jamil W; Selvaraj M; Uddin N; Rahim F
Bioorg Chem; 2019 Nov; 92():103235. PubMed ID: 31494327
[TBL] [Abstract][Full Text] [Related]
16. Spiro-Acridine Compound as a Pteridine Reductase 1 Inhibitor: in silico Target Fishing and in vitro Studies.
de Oliveira Viana J; Sena Mendes M; Santos Castilho M; Olímpio de Moura R; Guimarães Barbosa E
ChemMedChem; 2024 Jun; 19(11):e202300545. PubMed ID: 38445815
[TBL] [Abstract][Full Text] [Related]
17. Efficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents.
Zaheer Z; Khan FA; Sangshetti JN; Patil RH
EXCLI J; 2015; 14():935-47. PubMed ID: 26839526
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
[TBL] [Abstract][Full Text] [Related]
20. New thiophene-acridine compounds: Synthesis, antileishmanial activity, DNA binding, chemometric, and molecular docking studies.
de Lima Serafim V; Félix MB; Frade Silva DK; Rodrigues KADF; Andrade PN; de Almeida SMV; de Albuquerque Dos Santos S; de Oliveira JF; de Lima MDCA; Mendonça-Junior FJB; Scotti MT; de Oliveira MR; de Moura RO
Chem Biol Drug Des; 2018 Jun; 91(6):1141-1155. PubMed ID: 29415325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
